Skip to main content

EXPLORE

LCS

YOUR PREMIUM ASSET

The CATALYS® Precision Laser System brings together outstanding outcomes, ease-of-workflow integration and a premium patient experience to prime your practice for the future of cataract surgery.

PHACO

INCREDIBLE STABILITY

Engineered for flexibility, our phaco systems and accessories give you the outstanding performance you want so you can confidently apply your expertise at each stage of your procedures.

REFRACTIVE

TRUSTED TECHNOLOGIES

Backed by proven technology, proven results and proven versatility, our refractive systems create a comprehensive suit of technologies to help you deliver excellent outcomes to your patients.

DISCOVER

Customer Support

IOLS AND IMPLANTS

See our vast selection of intraocular lenses and implants.

Customer Support

CUSTOMER SUPPORT

Explore resources for equipment education and practice development, as well as our online tools.

INDICATIONS AND IMPORTANT SAFETY INFORMATION

Rx Only

FOR THE CATALYS® PRECISION LASER SYSTEM
INDICATIONS

The OptiMedica® CATALYS® Precision Laser System is indicated for use in patients undergoing cataract surgery for removal of the crystalline lens. Intended uses in cataract surgery include anterior capsulotomy, phacofragmentation, and the creation of single plane and multi-plane arc cuts/incisions in the cornea, each of which may be performed either individually or consecutively during the same procedure.

WARNINGS

Prior to INTEGRAL GUIDANCE System imaging and laser treatment, the suction ring must be completely filled with sterile buffered saline solution.

See Full Indications and Important Safety Information.

FOR THE WHITESTAR SIGNATURE® PRO PHACOEMULSIFICATION SYSTEM
INDICATIONS

The WHITESTAR SIGNATURE® PRO System is a modular ophthalmic microsurgical system that facilitates anterior segment (cataract) surgery. The modular design allows the users to configure the system to meet their surgical requirements.

WARNINGS

All personnel who might operate this equipment must read and understand the instructions in this manual before they use the system.

See Full Indications and Important Safety Information.

FOR THE COMPACT INTUITIV PHACOEMULSIFICATION SYSTEM
INDICATIONS

The COMPACT INTUITIV System is an AC-powered device with a fragmenting needle for cataract surgery to disrupt a cataract with ultrasound and extract the cataract. The Single-Use Pack is used with the COMPACT INTUITIV System. The Single-Use Pack is sterilized using Ethylene Oxide and is designed for single use only.

SAFETY PRECAUTIONS

Read the following safety precautions and warnings carefully before you use the system in surgery. Do not use extension cords with your machine.

See Full Indications and Important Safety Information.

FOR THE STABILEYES CAPSULAR TENSION RING
INDICATIONS

CTRs are indicated for the stabilization of weakened, broken or missing zonules that are suspected or observed during cataract extraction using phacoemulsification and continu­ous curvilinear capsulorhexis techniques in adults.

CONTRAINDICATIONS

CTRs should not be used in the presence of a torn or compromised capsular bag or significant, progressive pseudoexfoliation. CTRs should not be used in patients 12 years old or younger due to the developing eye.

WARNINGS

The long-term effects of progressive zonular stability following implantation of a CTR are not known.

See Full Indications and Important Safety Information.

FOR THE iFS® FEMTOSECOND LASER
INDICATIONS

The IntraLase® FS and iFS® Lasers are precision ophthalmic surgical lasers indicated for use in patients undergoing surgery or treatment requiring initial lamellar resection of the cornea and to create tunnels for placement of corneal ring segments, in lamellar keratoplasty and corneal harvesting, in the creation of a corneal flap in patients undergoing LASIK surgery, and in the creation of a lamellar cut / resection of the cornea for lamellar keratoplasty(IntraLase-Enabled Keratoplasty or IEK), and in the creation of a penetrating cut/incision for penetrating keratoplasty (or IEK). The iFS Laser is also indicated for use in penetrating and/or intrastromal arcuate incisions, and for patients undergoing ophthalmic surgery or other treatment requiring the creation of corneal channels for placement/ insertion of a corneal inlay device.

CONTRAINDICATIONS

Lamellar resection for the creation of a corneal flap is contraindicated in the presence of corneal edema, corneal lesions, hypotony, glaucoma, existing corneal implant or keratoconus. IEK procedures and arcuate incisions are contraindicated in the presence of any corneal opacity adequately dense to obscure visualization of the iris, descemetocoele with impending corneal rupture, previous corneal incisions that might provide a potential space into which the gas produced by the procedure can escape, or corneal thickness requirements that are beyond the range of the system. U.S. Federal Law restricts this device to sale, distribution, and use by or on the order of a physician or other licensed eye care professional. The product may contain mercury. Please dispose accordingly to state, local or federal laws.

See Full Indications and Important Safety Information.

FOR THE STAR S4 IR® EXCIMER LASER and iDESIGN® REFRACTIVE STUDIO SYSTEM
Indications for Use

The STAR S4 IR® Excimer Laser System and the iDESIGN® Refractive Studio are indicated for wavefront-guided laser assisted in situ keratomileusis (LASIK) for monovision treatment of presbyopic patients with low to moderate myopia with and without astigmatism; myopia up to -11.00 D , with astigmatism up to -5.00 D; mixed astigmatism from 1 to 5 diopters; hyperopia up to 4 diopters (D) with astigmatism, between 0 and 2 D.

Important Safety Information

Contraindications: Laser refractive surgery is contraindicated in patients with collagen vascular, autoimmune or immunodeficiency diseases, in pregnant or nursing women, in patients with corneal abnormalities including signs of keratoconus, abnormal corneal topography, epithelial basement membrane disease (EBMD) and degenerations of the structure of the cornea, in patients with symptoms of significant dry eyes. If the patients have severely dry eyes, LASIK may increase the dryness. This may or may not go away. Severe eye dryness may delay healing of the flap or interfere with the surface of the eye after surgery. It may result in poor vision after LASIK, in patients whose corneal thickness would cause anticipated treatment would violate the posterior 250 microns (μm) of corneal stroma, in patients with advanced glaucoma, in patients with uncontrolled diabetes, in patients with documented evidence of a change in manifest refraction of more than +0.5 D (in both cylinder and sphere components) for at least one year prior to the date of pre-operative examination. in patients taking medications with ocular side effects. Examples are Isotretinoin (Accutane®) for acne treatment or Amiodarone hydrochloride (Cordarone®) for normalizing heart rhythm.

Warnings: LASIK is not recommended in patients who have systemic diseases likely to affect wound healing, such as autoimmune connective tissue disease, diabetes or an immunocompromised status in patients have a history of Herpes simplex or Herpes zoster keratitis, severe allergies or tendency rub their eyes often, glaucoma, elevated IOP, ocular hypertension or being followed for possible glaucoma (glaucoma suspect), patients who are taking the medication Isotretinoin (Accutane) and antimetabolites for any medical conditions.

Precautions: To reduce the risk of corneal ectasia, the posterior 250 microns (µm) of corneal stroma should not be violated. Please refer to Operator’s Manual for a list of additional Precautions

Adverse Events: Prior clinical study of monovision LASIK using the WaveScan WaveFront® System aberrometer, supports the safety and effectiveness of iDESIGN® driven Monovision LASIK Treatment. Please refer to Operator’s Manual for a list of Adverse Events and complications in clinical studies for Monovision in Presbyopic Patients with Low to Moderate Myopia and Myopic Astigmatism, Myopia, Mixed Astigmatism and Hyperopia.

Please see full Indications and Safety Information for the iDesign® System and STAR S4 IR® Excimer Laser System.

PP2018MLT4177